dosist™ Launches Advanced CBD+ Topical Collection to Help Address Pain
3 min readPublished On: May 18th, 2021By News Team
LOS ANGELES– dosist™ today announced the launch of its progressive new range of CBD+ topical products aimed at disrupting the pain category with all-natural solutions designed to help with pain relief. Launched under their newly created dosist health brand, the innovative relief products include three formats, the Relief Topical Performance Spray, Relief Topical CBD Lotion and a Relief Topical CBD Roll-on, now available at dosisthealth.com and exclusive US retailers.
“We spent the last 3 years developing topical analgesics formulated with precise measurements of cannabinoids and natural botanical ingredients in addition to sophisticated absorption technology to help mitigate pain and inflammation,” said Jason DeLand, executive chairman and co-founder of dosist. “We believe that happiness is the highest form of health, and each product within our dosist health CBD+ category is thoughtfully and scientifically engineered to help people improve their quality of life.”
dosist health relief formulas advance the topical category with their unique blend of cannabinoids, delivering the very highest standards in potency, formulation design, absorption, and packaging design. The complete suite of dosist health topical solutions is specifically designed to help relieve pain associated with general muscle soreness and inflammatory pain resulting from overuse, minor sports injuries or simply nagging pain from the stresses of everyday life.
Leading the relief topical category is the new Topical Performance Spray, which delivers an advanced formula with proprietary nanoblend™ technology for rapid absorption. This performance formula combines powerful CBD, CBG and CBC for a high concentration lightweight formula, designed with performance athletes in mind. The addition of active plant ingredients such as capsicum, menthol and arnica are proven to aid in relieving pain and inflammation and assist with physical recovery.
Next are the Topical CBD Lotion and Topical CBD Roll-On, each combining precise measured ratios of highly purified cannabinoids CBD and CBG with active plant ingredients such as capsicum and menthol, for high-concentration formulas to help with areas of pain, stiffness or soreness.
“Cannabinoids, terpenes and natural phytochemicals are incredible natural conduits in helping many quality-of-life needs that modern consumers face,” continued Jason DeLand. “It is our mission to optimize these elements to unlock these needs through our scientific formulas, precision dosage and increased bioavailability, and we are thrilled to bring this platform to the topical pain relief category across the US today.”
Product details & pricing:
Topical Performance Spray – MSRP $49, The proprietary performance relief oil is best for those in active recovery and can be used to help assist active athletes over a period of time to reduce pain, increase circulation and promote healing. The sleek pump-action spray contains 750mg of cannabinoids per bottle, including: 375mg CBD, 250mg CBG, and 125mg CBC, plus the active plant ingredients in capsicum, menthol and arnica, and also includes dosist’s proprietary nanoblend™ technology for rapid absorption.
Topical CBD Lotion – MSRP $44, The dosist health topical lotion combines soothing cannabinoids CBD and CBG with the active plant ingredients in capsicum, menthol and arnica, for a high-concentration topical formula to help relieve pain in the joints. The rich and moisturizing lotion is great for general pain over a wide area of coverage. Contains 825mg of cannabinoids, including: 750mg CBD, 75mg CBG.
Topical CBD Roll-On – MSRP $38, The dosist health topical roll-on is a lightweight oil in a convenient roll-on application format, perfect for those on-the-go, and combines the active plant ingredients in capsicum, menthol, avocado oil and nigella seed oil with a potent dose of CBD and CBG cannabinoids, for an oil formula that helps with aches and pains. The topical roll-on contains 550mg of cannabinoids, including: 500mg CBD, 50mg CBG.
Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
BERLIN-- The International Cannabis Business Conference (ICBC) is gearing up for a timely and significant political discussion on cannabis policy reform in Germany. Building on the historic panel discussion held in 2021, where all major ...
TORONTO-- Canadian cannabis company Cronos Group Inc. has revealed plans to discontinue its hemp-derived CBD operations in the United States by the end of the second quarter of this year. The decision is aimed at ...
NEW YORK–In an effort to stabilize New York's adult-use marijuana program, which has experienced a rocky rollout, new legislation and significant policy shifts have been proposed. One of the key changes is the potential entry ...
DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more